Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus

Clinical Oncology

Volumn 9, Issue 5, 1997, Pages 313-321

  Coyle, D ^a,c   Drummond, M F ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF YORK   (United Kingdom)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Cancer; Cost analysis; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMMUNITY CARE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEAD CANCER; HEALTH CARE COST; HOSPITAL COST; HOSPITAL MANAGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MANPOWER PLANNING; META ANALYSIS; MULTICENTER STUDY; NECK CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESOURCE MANAGEMENT; TRAVEL; TREATMENT PLANNING;

EID: 9844232041     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(05)80065-2     Document Type: Article

References (19)

1. Goddard M, Hutton J. The costs of radiotherapy in cancer treatment (Centre for Health Economics Discussion Paper 48). York: University of York, 1988.
2. Greene D. The cost of radiotherapy treatments on a linear accelerator. Br J Radiol 1983;56:189-91.
3. Atherton L. The cost of radiotherapy treatments on a linear accelerator. Br J Radiol 1984;57:106-7.
4. Hughes DJ, McEvedy MB. The effective cost of medical technology. Manage Accounting 1981;(Feb):38-9.
5. Saunders MI, Dische S, Barrett A, et al. Randomised multicentre trails of CHART vs. conventional radiotherapy in head and neck and non-small-cell lung cancer - an interim report. Br J Cancer 1996;73:1455-62.
6. de Haes J, van Knippenberg F, Neijt J. Measuring the psychosocial and physical distress of cancer patients: the structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990;62:1034-8.
7. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
8. Drummond MF, Davies L. Economic analysis alongside clinical trials: revisiting the methodological issues. Int J Technol Assess Health Care 1991;7:561-73.
9. Coyle D. Statistical analysis in pharmacoeconomic studies: a review of current issues and standards. Pharmacoeconomics 1996;9:506-16
10. O'Brien BJ, Drummond MF, Labelle RJ, et al. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994;32:150-63.
11. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987.
12. York Health Authority District Finance Department. National ambulance service survey 1990-1991: financial and statistical information; metropolitan and non-metropolitan services. York: York Health Authority, 1992.
13. Netten A, Smart S. Unit cost of community care 1992/93. Canterbury: University of Kent Personal Social Services Research Unit, 1993.
14. Thomas K, Birch S, Milner P, et al. Estimates of general practitioner workload: a review. J R Coll Gen Pract 1989;39:509-13.
15. Royal Commission on the NHS: report. London: HMSO, 1979.
16. Groves D, Nash A. A friendship that inspires hope. A study of Macmillan nurses' working patterns. Prof Nurse 1992; (Apr):478-85.
17. AA Technical Services. Motoring costs. Basingstoke: Automobile Association, 1993.
18. Department of Transport. Transport Statistics Great Britain. London: HMSO, 1990.
19. Drummond MF, Menzin J, Oster G. Methodological issues in economic assessments of new therapies. The case of colony-stimulating factors. Pharmacoeconomics 1994;6(Suppl 2):18-26.